Global Tumor Biomarker Test Market Research Report 2023

The global Tumor Biomarker Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Tumor Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Tumor Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Tumor Biomarker Test in Lung cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Tumor Biomarker Test include Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc. and Illumina Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Biomarker Test.

The Tumor Biomarker Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tumor Biomarker Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Prostate Specific Antigen Tests

1.2.3 CTC Tests

1.2.4 Alpha-Fetoprotein (AFP) Tests

1.2.5 CA Test

1.2.6 HER2 Tests

1.2.7 BRCA Test

1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests

1.2.9 EGFR Mutation Tests

1.2.10 KRAS Test

1.2.11 Others

1.3 Market by Application

1.3.1 Global Tumor Biomarker Test Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Lung cancer

1.3.3 Breast cancer

1.3.4 Colorectal

1.3.5 Prostate Cancer

1.3.6 Blood Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Tumor Biomarker Test Market Perspective (2018-2029)

2.2 Tumor Biomarker Test Growth Trends by Region

2.2.1 Global Tumor Biomarker Test Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Tumor Biomarker Test Historic Market Size by Region (2018-2023)

2.2.3 Tumor Biomarker Test Forecasted Market Size by Region (2024-2029)

2.3 Tumor Biomarker Test Market Dynamics

2.3.1 Tumor Biomarker Test Industry Trends

2.3.2 Tumor Biomarker Test Market Drivers

2.3.3 Tumor Biomarker Test Market Challenges

2.3.4 Tumor Biomarker Test Market Restraints

3.1 Global Top Tumor Biomarker Test Players by Revenue

3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2018-2023)

3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2018-2023)

3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Tumor Biomarker Test Revenue

3.4 Global Tumor Biomarker Test Market Concentration Ratio

3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2022

3.5 Tumor Biomarker Test Key Players Head office and Area Served

3.6 Key Players Tumor Biomarker Test Product Solution and Service

3.7 Date of Enter into Tumor Biomarker Test Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Tumor Biomarker Test Historic Market Size by Type (2018-2023)

4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2024-2029)

5.1 Global Tumor Biomarker Test Historic Market Size by Application (2018-2023)

5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2024-2029)

6.1 North America Tumor Biomarker Test Market Size (2018-2029)

6.2 North America Tumor Biomarker Test Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Tumor Biomarker Test Market Size by Country (2018-2023)

6.4 North America Tumor Biomarker Test Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Tumor Biomarker Test Market Size (2018-2029)

7.2 Europe Tumor Biomarker Test Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Tumor Biomarker Test Market Size by Country (2018-2023)

7.4 Europe Tumor Biomarker Test Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Tumor Biomarker Test Market Size (2018-2029)

8.2 Asia-Pacific Tumor Biomarker Test Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Tumor Biomarker Test Market Size by Region (2018-2023)

8.4 Asia-Pacific Tumor Biomarker Test Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Tumor Biomarker Test Market Size (2018-2029)

9.2 Latin America Tumor Biomarker Test Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Tumor Biomarker Test Market Size by Country (2018-2023)

9.4 Latin America Tumor Biomarker Test Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Tumor Biomarker Test Market Size (2018-2029)

10.2 Middle East & Africa Tumor Biomarker Test Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Tumor Biomarker Test Market Size by Country (2018-2023)

10.4 Middle East & Africa Tumor Biomarker Test Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott Laboratories, Inc.

11.1.1 Abbott Laboratories, Inc. Company Detail

11.1.2 Abbott Laboratories, Inc. Business Overview

11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction

11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.1.5 Abbott Laboratories, Inc. Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Tumor Biomarker Test Introduction

11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2018-2023)

11.2.5 Agilent Technologies Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Detail

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Tumor Biomarker Test Introduction

11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2018-2023)

11.3.5 AstraZeneca Recent Development

11.4 Becton Dickinson & Co.

11.4.1 Becton Dickinson & Co. Company Detail

11.4.2 Becton Dickinson & Co. Business Overview

11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction

11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2018-2023)

11.4.5 Becton Dickinson & Co. Recent Development

11.5 Biocept Inc.

11.5.1 Biocept Inc. Company Detail

11.5.2 Biocept Inc. Business Overview

11.5.3 Biocept Inc. Tumor Biomarker Test Introduction

11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.5.5 Biocept Inc. Recent Development

11.6 Cancer Genetics Inc.

11.6.1 Cancer Genetics Inc. Company Detail

11.6.2 Cancer Genetics Inc. Business Overview

11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction

11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.6.5 Cancer Genetics Inc. Recent Development

11.7 Danaher Corporation

11.7.1 Danaher Corporation Company Detail

11.7.2 Danaher Corporation Business Overview

11.7.3 Danaher Corporation Tumor Biomarker Test Introduction

11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2018-2023)

11.7.5 Danaher Corporation Recent Development

11.8 Foundation Medicine Inc.

11.8.1 Foundation Medicine Inc. Company Detail

11.8.2 Foundation Medicine Inc. Business Overview

11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction

11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.8.5 Foundation Medicine Inc. Recent Development

11.9 Illumina Inc.

11.9.1 Illumina Inc. Company Detail

11.9.2 Illumina Inc. Business Overview

11.9.3 Illumina Inc. Tumor Biomarker Test Introduction

11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.9.5 Illumina Inc. Recent Development

11.10 LabCorp Of America Holdings

11.10.1 LabCorp Of America Holdings Company Detail

11.10.2 LabCorp Of America Holdings Business Overview

11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction

11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2018-2023)

11.10.5 LabCorp Of America Holdings Recent Development

11.11 Luminex Corporation

11.11.1 Luminex Corporation Company Detail

11.11.2 Luminex Corporation Business Overview

11.11.3 Luminex Corporation Tumor Biomarker Test Introduction

11.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2018-2023)

11.11.5 Luminex Corporation Recent Development

11.12 Myriad Genetics Inc.

11.12.1 Myriad Genetics Inc. Company Detail

11.12.2 Myriad Genetics Inc. Business Overview

11.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction

11.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.12.5 Myriad Genetics Inc. Recent Development

11.13 NanoString Technologies Inc.

11.13.1 NanoString Technologies Inc. Company Detail

11.13.2 NanoString Technologies Inc. Business Overview

11.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction

11.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2018-2023)

11.13.5 NanoString Technologies Inc. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Prostate Specific Antigen Tests

    Table 3. Key Players of CTC Tests

    Table 4. Key Players of Alpha-Fetoprotein (AFP) Tests

    Table 5. Key Players of CA Test

    Table 6. Key Players of HER2 Tests

    Table 7. Key Players of BRCA Test

    Table 8. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests

    Table 9. Key Players of EGFR Mutation Tests

    Table 10. Key Players of KRAS Test

    Table 11. Key Players of Others

    Table 12. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 13. Global Tumor Biomarker Test Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 14. Global Tumor Biomarker Test Market Size by Region (2018-2023) & (US$ Million)

    Table 15. Global Tumor Biomarker Test Market Share by Region (2018-2023)

    Table 16. Global Tumor Biomarker Test Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 17. Global Tumor Biomarker Test Market Share by Region (2024-2029)

    Table 18. Tumor Biomarker Test Market Trends

    Table 19. Tumor Biomarker Test Market Drivers

    Table 20. Tumor Biomarker Test Market Challenges

    Table 21. Tumor Biomarker Test Market Restraints

    Table 22. Global Tumor Biomarker Test Revenue by Players (2018-2023) & (US$ Million)

    Table 23. Global Tumor Biomarker Test Market Share by Players (2018-2023)

    Table 24. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2022)

    Table 25. Ranking of Global Top Tumor Biomarker Test Companies by Revenue (US$ Million) in 2022

    Table 26. Global 5 Largest Players Market Share by Tumor Biomarker Test Revenue (CR5 and HHI) & (2018-2023)

    Table 27. Key Players Headquarters and Area Served

    Table 28. Key Players Tumor Biomarker Test Product Solution and Service

    Table 29. Date of Enter into Tumor Biomarker Test Market

    Table 30. Mergers & Acquisitions, Expansion Plans

    Table 31. Global Tumor Biomarker Test Market Size by Type (2018-2023) & (US$ Million)

    Table 32. Global Tumor Biomarker Test Revenue Market Share by Type (2018-2023)

    Table 33. Global Tumor Biomarker Test Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 34. Global Tumor Biomarker Test Revenue Market Share by Type (2024-2029)

    Table 35. Global Tumor Biomarker Test Market Size by Application (2018-2023) & (US$ Million)

    Table 36. Global Tumor Biomarker Test Revenue Market Share by Application (2018-2023)

    Table 37. Global Tumor Biomarker Test Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 38. Global Tumor Biomarker Test Revenue Market Share by Application (2024-2029)

    Table 39. North America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. North America Tumor Biomarker Test Market Size by Country (2018-2023) & (US$ Million)

    Table 41. North America Tumor Biomarker Test Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Europe Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Europe Tumor Biomarker Test Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Europe Tumor Biomarker Test Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Asia-Pacific Tumor Biomarker Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Asia-Pacific Tumor Biomarker Test Market Size by Region (2018-2023) & (US$ Million)

    Table 47. Asia-Pacific Tumor Biomarker Test Market Size by Region (2024-2029) & (US$ Million)

    Table 48. Latin America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Latin America Tumor Biomarker Test Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Latin America Tumor Biomarker Test Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Middle East & Africa Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 52. Middle East & Africa Tumor Biomarker Test Market Size by Country (2018-2023) & (US$ Million)

    Table 53. Middle East & Africa Tumor Biomarker Test Market Size by Country (2024-2029) & (US$ Million)

    Table 54. Abbott Laboratories, Inc. Company Detail

    Table 55. Abbott Laboratories, Inc. Business Overview

    Table 56. Abbott Laboratories, Inc. Tumor Biomarker Test Product

    Table 57. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 58. Abbott Laboratories, Inc. Recent Development

    Table 59. Agilent Technologies Company Detail

    Table 60. Agilent Technologies Business Overview

    Table 61. Agilent Technologies Tumor Biomarker Test Product

    Table 62. Agilent Technologies Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 63. Agilent Technologies Recent Development

    Table 64. AstraZeneca Company Detail

    Table 65. AstraZeneca Business Overview

    Table 66. AstraZeneca Tumor Biomarker Test Product

    Table 67. AstraZeneca Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 68. AstraZeneca Recent Development

    Table 69. Becton Dickinson & Co. Company Detail

    Table 70. Becton Dickinson & Co. Business Overview

    Table 71. Becton Dickinson & Co. Tumor Biomarker Test Product

    Table 72. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 73. Becton Dickinson & Co. Recent Development

    Table 74. Biocept Inc. Company Detail

    Table 75. Biocept Inc. Business Overview

    Table 76. Biocept Inc. Tumor Biomarker Test Product

    Table 77. Biocept Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 78. Biocept Inc. Recent Development

    Table 79. Cancer Genetics Inc. Company Detail

    Table 80. Cancer Genetics Inc. Business Overview

    Table 81. Cancer Genetics Inc. Tumor Biomarker Test Product

    Table 82. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 83. Cancer Genetics Inc. Recent Development

    Table 84. Danaher Corporation Company Detail

    Table 85. Danaher Corporation Business Overview

    Table 86. Danaher Corporation Tumor Biomarker Test Product

    Table 87. Danaher Corporation Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 88. Danaher Corporation Recent Development

    Table 89. Foundation Medicine Inc. Company Detail

    Table 90. Foundation Medicine Inc. Business Overview

    Table 91. Foundation Medicine Inc. Tumor Biomarker Test Product

    Table 92. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 93. Foundation Medicine Inc. Recent Development

    Table 94. Illumina Inc. Company Detail

    Table 95. Illumina Inc. Business Overview

    Table 96. Illumina Inc. Tumor Biomarker Test Product

    Table 97. Illumina Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 98. Illumina Inc. Recent Development

    Table 99. LabCorp Of America Holdings Company Detail

    Table 100. LabCorp Of America Holdings Business Overview

    Table 101. LabCorp Of America Holdings Tumor Biomarker Test Product

    Table 102. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 103. LabCorp Of America Holdings Recent Development

    Table 104. Luminex Corporation Company Detail

    Table 105. Luminex Corporation Business Overview

    Table 106. Luminex Corporation Tumor Biomarker Test Product

    Table 107. Luminex Corporation Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 108. Luminex Corporation Recent Development

    Table 109. Myriad Genetics Inc. Company Detail

    Table 110. Myriad Genetics Inc. Business Overview

    Table 111. Myriad Genetics Inc. Tumor Biomarker Test Product

    Table 112. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 113. Myriad Genetics Inc. Recent Development

    Table 114. NanoString Technologies Inc. Company Detail

    Table 115. NanoString Technologies Inc. Business Overview

    Table 116. NanoString Technologies Inc. Tumor Biomarker Test Product

    Table 117. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2018-2023) & (US$ Million)

    Table 118. NanoString Technologies Inc. Recent Development

    Table 119. Research Programs/Design for This Report

    Table 120. Key Data Information from Secondary Sources

    Table 121. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Tumor Biomarker Test Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Tumor Biomarker Test Market Share by Type: 2022 VS 2029

    Figure 3. Prostate Specific Antigen Tests Features

    Figure 4. CTC Tests Features

    Figure 5. Alpha-Fetoprotein (AFP) Tests Features

    Figure 6. CA Test Features

    Figure 7. HER2 Tests Features

    Figure 8. BRCA Test Features

    Figure 9. Anaplastic Lymphoma Kinase (ALK) Tests Features

    Figure 10. EGFR Mutation Tests Features

    Figure 11. KRAS Test Features

    Figure 12. Others Features

    Figure 13. Global Tumor Biomarker Test Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 14. Global Tumor Biomarker Test Market Share by Application: 2022 VS 2029

    Figure 15. Lung cancer Case Studies

    Figure 16. Breast cancer Case Studies

    Figure 17. Colorectal Case Studies

    Figure 18. Prostate Cancer Case Studies

    Figure 19. Blood Cancer Case Studies

    Figure 20. Tumor Biomarker Test Report Years Considered

    Figure 21. Global Tumor Biomarker Test Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 22. Global Tumor Biomarker Test Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 23. Global Tumor Biomarker Test Market Share by Region: 2022 VS 2029

    Figure 24. Global Tumor Biomarker Test Market Share by Players in 2022

    Figure 25. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2022)

    Figure 26. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2022

    Figure 27. North America Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. North America Tumor Biomarker Test Market Share by Country (2018-2029)

    Figure 29. United States Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Canada Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Europe Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Europe Tumor Biomarker Test Market Share by Country (2018-2029)

    Figure 33. Germany Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. France Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. U.K. Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Italy Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Russia Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Nordic Countries Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Asia-Pacific Tumor Biomarker Test Market Share by Region (2018-2029)

    Figure 41. China Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Japan Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. South Korea Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. India Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Australia Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Latin America Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Latin America Tumor Biomarker Test Market Share by Country (2018-2029)

    Figure 49. Mexico Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Brazil Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Tumor Biomarker Test Market Share by Country (2018-2029)

    Figure 53. Turkey Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 54. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 55. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 56. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 57. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 58. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 59. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 60. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 61. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 62. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 63. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 64. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 65. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 66. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 67. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2018-2023)

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed